A federal judge in the US District Court for the Southern District of New York has dismissed an important part of the law suit brought by health care giant Johnson & Johnson against the American Red Cross seeking to restrict the latter's use of its emblem on first aid, health, safety and emergency preparedness products (Marketletter August 13). The judge's ruling dismissed entirely the drugmaker's claim that the Red Cross promised not to engage in the sale of such items.
"I appreciate the court's decision and hope that Johnson & Johnson will reassess their actions and drop the case altogether," said Mark Everson, president of the American Red Cross.
Following a hearing on October 29, Judge Jed Rakoff later ruled that the "promissory estoppel" claim, a very significant portion of the pharmaceutical company's law suit against the Red Cross, was "dismissed with prejudice." The judge's ruling also means that J&J cannot refile arguments on this claim.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze